CDSCO nod to AstraZeneca to import, sell hyperkalaemia treatment drug in India Ruchika Sharma7 March 2025 12:30 PM ISTAstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation (CDSCO), Directorate General of...
Drug Safety Alert: IPC Flags Adverse Reactions to Amphotericin B and Carbimazole Susmita Roy6 Dec 2024 6:00 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of November, has revealed adverse...
AstraZeneca discontinues 2 Phase III evidence trials for Lokelma Ruchika Sharma4 Dec 2023 4:00 PM ISTThe decision to discontinue the trials is not due to safety concerns and the positive benefit-risk of Lokelma does not change in the approved...
Too much black licorice candy cost man his life: NEJM case report Dr. Kamal Kant Kohli25 Sept 2020 5:34 PM ISTDr Elazer R. Edelman at Department of Medicine, Brigham and Women's Hospital and associates have reported a case of death of a man after eating bags...
AstraZeneca in talks to buy cancer drugmaker Acerta for $5 billion: WSJ savita thakur thakur12 Dec 2015 11:14 AM ISTBritish drugmaker AstraZeneca Plc is in advanced talks to buy privately held cancer drug developer Acerta Pharma BV for more than $5 billion (3.3...
AstraZeneca buys ZS Pharma for $2.7 billion, pips Actelion Pooja Bhatia Bhatia7 Nov 2015 9:00 AM ISTLondon: Britain's AstraZeneca has said that it had agreed to buy U.S biotech company ZS Pharma for $2.7 billion, pipping Swiss firm Actelion to...
